Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

mREITs Begin Their Plunge: Annaly Capital Management, Inc. (NLY), ARMOUR Residential REIT, Inc. (ARR) & More

Last summer, Federal Housing Finance Agency chief Edward DeMarco made a fatal mistake: He flatly refused to consider principal reduction on underwater mortgage loans backed by Fannie Mae and Freddie Mac. Perhaps DeMarco thought an Obama reelection wasn’t in the cards, or maybe he really was concerned about the use of public funds toward such an endeavor. At any rate, rumors of his ouster were prescient, as President Obama has just nominated a replacement, Representative Mel Watt, a Democrat from Charlotte, North Carolina.

Annaly Capital Management, Inc. (NYSE:NLY)

Mortgage REITs begin their plunge
It didn’t take long for investors to show their concern, and by mid-afternoon yesterday, Annaly Capital Management, Inc. (NYSE:NLY) and fellow agency players American Capital Agency Corp. (NASDAQ:AGNC) Agency and ARMOUR Residential REIT, Inc. (NYSE:ARR) had dropped by at least .90% from the opening bell. By the market’s close, each fell by 0.69%, 0.87%, and 1.23%, sequentially.

Investors may feel that Watt will be much more open to the principal-reduction scenario — which would unleash a rash of prepayments possibly never seen before, as owners of troubled home loans not previously eligible to do so rush to refinance under more amenable terms.

Are they right? Could be. Watt has a history of consumer-protection leanings, having co-sponsored the Credit Card Accountability, Responsibility and Disclosure Act of 2009, in addition to advocating for the revamping of mortgage lending procedures. Despite these activities, he hasn’t alienated Wall Street, and has been a recipient of healthy campaign contributions from both banks and insurers, according to The Wall Street Journal.

Not a shoo-in
Watt faces a tough nomination process, however. Obama’s previous effort to replace DeMarco ended in failure two years ago, when Republican hostility caused that candidate to withdraw. Watt’s left-of-center views, including his support of making home loans more available to low-income and minority borrowers, will likely not endear him to the political right. Senator Bob Corker, R-Tennessee, has already been quite vocal in his dismay regarding Obama’s plan to nominate Watt, labeling the choice as “political” and comparable to “the fox…guarding the hen house.”

Despite these roadblocks, the Obama administration will certainly be better positioned to fend off opposition this time around, and Watt’s nomination has already gotten the thumbs-up from several influential politicians, including Erskine Bowles and Alan Simpson, co-chairs of Obama’s Deficit Commission.

If Watt emerges victorious, mREITs will be in a more precarious position than they were last November, when banks were inundated with refinance work, and were therefore unlikely to take on more even if it came their way. With the mortgage business drying up, though, this threat looms larger than ever.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.